Role of pre-existing redox profile of human macrophages on lipid synthesis and cholesteryl ester cycle in presence of native, acetylated and oxidised low density lipoprotein

Author(s):  
Elena Bravo ◽  
Mariarosaria Napolitano ◽  
Roberto Rivabene
2014 ◽  
Vol 11 (6) ◽  
pp. 410-418 ◽  
Author(s):  
Daniel James Shaw ◽  
Rachel Seese ◽  
Sreenivasan Ponnambalam ◽  
Ramzi Ajjan

The lectin-like oxidised low-density lipoprotein receptor-1 (LOX-1) is a vascular scavenger receptor that plays a central role in the pathogenesis of atherothrombotic disease, which remains the main cause of mortality in the Western population. Recent evidence indicates that targeting LOX-1 represents a credible strategy for the management vascular disease and the current review explores the role of this molecule in the diagnosis and treatment of atherosclerosis. LOX-1-mediated pro-atherogenic effects can be inhibited by anti-LOX-1 monoclonal antibodies and procyanidins, whereas downregulation of LOX-1 expression has been achieved by antisense oligonucleotides and a specific pyrrole–imidazole polyamide. Furthermore, LOX-1 can be utilised for plaque imaging using monoclonal antibodies and even the selective delivery of anti-atherosclerotic agents employing immunoliposome techniques. Also, plasma levels of the circulating soluble form of LOX-1 levels are elevated in atherosclerosis and therefore may constitute an additional diagnostic biomarker of vascular pathology.


2001 ◽  
Vol 156 (1) ◽  
pp. 133-144 ◽  
Author(s):  
Karin Müller ◽  
Simon Dulku ◽  
Simon J Hardwick ◽  
Jeremy N Skepper ◽  
Malcolm J Mitchinson

Sign in / Sign up

Export Citation Format

Share Document